Macrolide resistant Streptococcus pyogenes isolates from Finland, Australia and Britain, and more recently, Streptococcus pneumoniae and S. pyogenes strains from the United States have shown that the unusual resistance macrolides, lincosamides and streptogramin B antibiotics. This model, known as M resistance, consists of susceptibility to clindamycin and streptogramin B antibiotics but resistance in 14 - and 15-membered macrolides. Score makrolydam lincosamide-streptogramin B resistance phenotypes among our streptococcal strains collected from 1993 to 1995 suggested that the unusual nature of this resistance is not uncommon. Eighty-five percent (n = 66) S.pneumoniae and 75% (n = 28) S. pyogenes strains in our collection were phenotype M. The mechanism of resistance M is mediated by goal changes as separate ribosomes from pneumococcal strain bearing M buy strattera online phenotype were fully sensitive to erythromycin. Also, having metylaza IUR was excluded from the primers specific to ERM consensus sequence. However, the results of studies that determined the absorption and incorporation into the cells labeled erythromycin according to the presence of macrolides determine the end. Estimated end sets in streptococci seems different from multicomponent macrolide leakage of coagulase staphylococci. Recognition of the prevalence of M phenotype streptococci has implications for test sensitivity and may affect the choice of antibiotic therapy in clinical practice. .
No comments:
Post a Comment